跳至主要内容
临床试验/NCT04344002
NCT04344002已完成不适用

Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease

Spanish Lung Cancer Group75 个研究点 分布在 1 个国家目标入组 886 人开始时间: 2020年4月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
886
试验地点
75
主要终点
Treatments received

研究概览

简要总结

This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order to collect clinical data for the research. It will also include I on the care organization or the perception of the patient and their family members.

The final stage will consist on retrospective data collection from patients. So, it is a retrospective study data collection, preceded by prospective data registry.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with lung cancer
  • Patients who have contracted COVID-19 infection

排除标准

  • Patients diagnosed with lung cancer but no confirmation of COVID-19 infection.

结局指标

主要结局

Treatments received

时间窗: From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years

Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as treatments received

Clinical data of lung cancer patients with COVID-19 diagnoses

时间窗: From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years

Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as clinical data.

Prognostic factors

时间窗: From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years

Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as prognostic factors.

Diagnosis data

时间窗: From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years

Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as data about diagnosis

次要结局

未报告次要终点

研究者

发起方
Spanish Lung Cancer Group
申办方类型
Other
责任方
Sponsor

研究点 (75)

Loading locations...

相似试验

LunG and Melanoma canceR pAtients coVId19 Disease... | 临床试验